Search results
Researchers complete first trial of Black patients with early-stage breast cancer
Medical Xpress· 8 hours agoResults were presented today at the 2024 Annual Meeting of the American Society of Clinical Oncology...
Rep. Sheila Jackson Lee reveals she's been diagnosed with pancreatic cancer. Here's what to know...
Yahoo Life· 19 hours ago“If you think about where the...wrong.” The later the disease is diagnosed — using imaging scans —...
'I'd be dead by now': Canadians share breast cancer stories as new screening guidelines spark...
Yahoo Canada Style· 1 hour agoAlthough a federal task force says mammograms shouldn't be routine for women under 50, new data...
Fight the Fight, Find the Cure! 65+ Symbolic Breast Cancer Tattoos for Survivors and Loved Ones
Parade via AOL· 5 days agoHere are 65+ creative breast cancer tattoo ideas. 65+ Breast Cancer Tattoos 1. Breast& ...
Study finds more women in oil-rich Gulf countries battle with breast cancer
Medical Xpress· 22 hours agoThe panel was led by Humaid O. Al Shamsi, Oncology Professor at Sharjah University's College of...
Advanced breast cancer increases linked to screening in COVID-19 pandemic
Cosmos· 6 days agoCOVID-19 brought an unprecedented shift in the approach to breast cancer screening and treatment in...
Studies spotlight COVID-disrupted breast-cancer screening, cancer treatment delays or stoppage
Center for Infectious Disease Research and Policy· 6 days agocancer and COVID-19, and the characteristics of those most likely to discontinue treatment. For the...
Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024...
The Pilot News· 2 days ago...Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, will present a poster at the 2024 ASCO Annual Meeting entitled "Phase 1 study of BAT8006, a folate receptor α antibody drug conjugate with strong...
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 22 hours agoThe top-line results showed that the study did not meet the...carrying a Zacks Rank #2 (Buy) at...
...Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in...
Morningstar· 1 day ago("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy and Kintara ...